| 000 | 01299 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512223749.0 | ||
| 264 | 0 | _c19831221 | |
| 008 | 198312s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1983.tb02196.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarron, D W | |
| 245 | 0 | 0 |
_aAn assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cOct 1983 |
||
| 300 |
_a451-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aClonidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhysical Exertion |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aArndts, D | |
| 700 | 1 | _aFinch, M | |
| 700 | 1 | _aShanks, R G | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 16 _gno. 4 _gp. 451-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1983.tb02196.x _zAvailable from publisher's website |
| 999 |
_c6626258 _d6626258 |
||